Unity’s Runtime Fee is officially dead in the water. Exactly one year after its infamous announcement, new CEO Matt Bromberg has made his stamp on the firm - to end the madness and, to coin a sporting ...
Unity Biotechnology’s investigational eye treatment failed to match Eylea at 20 weeks—part of the mid-stage trial’s primary endpoint and the only time stamp out of 10 in which the candidate was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback